SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff is driving attention, with traders pointing to leveraged long liquidations and broader risk-off pressure. The community is split between buying an oversold dip near technical support and expecting further declines if selling continues.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Phase 3 REGAL trial of GPS has reached the 80th event, and the company expects topline results this month, driving intense attention ahead of the AML data readout. Traders celebrated a sharp after-hours move and speculated about a data leak or short covering, while others cautioned that the trial remains blinded and its outcome is unknown.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints from users whose work was interrupted. Traders debated whether the prolonged disruption should pressure the stock, which held near flat-to-positive, while some speculated about a cyberattack without confirmation.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is sliding alongside a broader crypto selloff, with traders pointing to risk-off sentiment, inflation and rate-hike concerns, and leveraged liquidations. The steep decline has sparked debate over whether support will hold or losses will deepen, while some holders are buying the dip and others cite stalled regulatory progress and weak demand as reasons for caution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure alongside Bitcoins slide and broader weakness in crypto-linked stocks, with traders highlighting fresh lows and arguing over whether the selloff has further to run or the shares are forming a base. Some also point to COINs underperformance versus Bitcoin and concerns about trading activity, while a smaller group sees an oversold bounce opportunity.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is drawing attention amid weakness in Ethereum and broader crypto-linked stocks, with traders focused on its ETH-treasury exposure and the shares decline. The community is split between dip-buyers expecting a recovery and critics questioning Tom Lees strategy, company spending, transparency and buybacks.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Brief India: Aequitas: Manipal Hospitals Pre-IPO - The Positives - Strong Earnings Growth and more

In this briefing: Aequitas: Manipal Hospitals Pre-IPO - The Positives - Strong Earnings Growth Primer: Motilal Oswal Financial Services (MOFS IN) - Apr 2026 USA + Israel Versus Iran War Damage Assessment (Day 43) TCS's Silent Leadership Crisis: When the Pyramid Cracks at the Top Primer: Tata Chemicals (TTCH IN) - Apr 2026 1. Aequitas: Manipal Hospitals Pre-IPO - The Positives - Strong Earnings Growth Manipal Health (MHEL) is looking to raise about US$1bn in its upcoming India IPO. MHEL operates a pan‑India network of multispecialty hospitals delivering a range of care services, from outpatient services to complex tertiary and quaternary interventions. In this note, we talk about the positive aspects of the deal. 2. Primer: Motilal Oswal Financial Services (MOFS IN) - Apr 2026 Motilal Oswal Financial Services (MOFS) is a well-diversified financial services firm with a strong brand and a comprehensive product suite, positioning it to capitalize on the long-term structural growth of India's financialization of savings.

Brief India: Primer: Motilal Oswal Financial Services (MOFS IN) - Apr 2026 and more

In this briefing: Primer: Motilal Oswal Financial Services (MOFS IN) - Apr 2026 USA + Israel Versus Iran War Damage Assessment (Day 43) TCS's Silent Leadership Crisis: When the Pyramid Cracks at the Top Primer: Tata Chemicals (TTCH IN) - Apr 2026 IPM Pharma Pulse March-25: Driven by Semaglutide Generics; Low Single Digit Growth Outlook for FY27 1. Primer: Motilal Oswal Financial Services (MOFS IN) - Apr 2026 Motilal Oswal Financial Services (MOFS) is a well-diversified financial services firm with a strong brand and a comprehensive product suite, positioning it to capitalize on the long-term structural growth of India's financialization of savings. The company is strategically shifting towards more stable, annuity-based revenue streams like wealth and asset management to counterbalance the inherent cyclicality and competitive pressures within the traditional broking business. While demonstrating impressive long-term growth in revenue and profitability, the company's earnings are highly sensitive to capital market cycles, and it faces intense competition from discount brokerage firms, which presents a key risk to its market share and margins.

Brief India: USA + Israel Versus Iran War Damage Assessment (Day 43) and more

In this briefing: USA + Israel Versus Iran War Damage Assessment (Day 43) TCS's Silent Leadership Crisis: When the Pyramid Cracks at the Top Primer: Tata Chemicals (TTCH IN) - Apr 2026 IPM Pharma Pulse March-25: Driven by Semaglutide Generics; Low Single Digit Growth Outlook for FY27 EM Fixed Income: Will EM markets keep trading Iran conflict de-escalation? 1. USA + Israel Versus Iran War Damage Assessment (Day 43) War-Related disruptions have removed c.4–5mb/d of oil supply and c.88mtpa of LNG capacity, marking a material but uneven shock to global energy markets. Oil markets remain buffered by spare capacity, while LNG losses—concentrated in key export hubs—pose a more durable constraint on global gas supply. Damage is skewed towards upstream production and LNG infrastructure, implying longer recovery timelines and sustained volatility in gas and refined products. 2. TCS's Silent Leadership Crisis: When the Pyramid Cracks at the Top TCS has logged its highest-ever senior-level attrition since its 2004 IPO: 16% among the top 1,800 leaders, with over 300 VPs and principal consultants departing in 8 months.

Brief India: TCS's Silent Leadership Crisis: When the Pyramid Cracks at the Top and more

In this briefing: TCS's Silent Leadership Crisis: When the Pyramid Cracks at the Top Primer: Tata Chemicals (TTCH IN) - Apr 2026 IPM Pharma Pulse March-25: Driven by Semaglutide Generics; Low Single Digit Growth Outlook for FY27 EM Fixed Income: Will EM markets keep trading Iran conflict de-escalation? Exencial Industry Tidings - 13-04-2026 1. TCS's Silent Leadership Crisis: When the Pyramid Cracks at the Top TCS has logged its highest-ever senior-level attrition since its 2004 IPO: 16% among the top 1,800 leaders, with over 300 VPs and principal consultants departing in 8 months. Senior exits don't just erode headcount. They sever client relationships, disrupt delivery continuity, and hollow out mentoring chains precisely the institutional muscle TCS needs to execute deals in AI-transformation era. The question for FY27 is whether TCS can protect delivery execution while simultaneously reinventing its operating model around AI. 2. Primer: Tata Chemicals (TTCH IN) - Apr 2026 Tata Chemicals is a global chemical company with a diversified portfolio of basic and specialty products, making it a key player in the industry.

Brief India: Primer: Tata Chemicals (TTCH IN) - Apr 2026 and more

In this briefing: Primer: Tata Chemicals (TTCH IN) - Apr 2026 IPM Pharma Pulse March-25: Driven by Semaglutide Generics; Low Single Digit Growth Outlook for FY27 EM Fixed Income: Will EM markets keep trading Iran conflict de-escalation? Exencial Industry Tidings - 13-04-2026 Bank of India (BOI IN) Vs Union Bank of India (UNBK IN): Repeat Pair Trade in PSU Banks 1. Primer: Tata Chemicals (TTCH IN) - Apr 2026 Tata Chemicals is a global chemical company with a diversified portfolio of basic and specialty products, making it a key player in the industry. The company holds a strong position as the world's third-largest producer of soda ash and a leading manufacturer of sodium bicarbonate. While facing near-term headwinds from global oversupply in the soda ash market, the company's focus on high-margin specialty chemicals and cost optimization provides a pathway for future growth and improved profitability. This content is AI-generated and displayed for general informational purposes only. Please verify independently before use. 2.

At ₹900, Is Tata Chemicals A Buy? SEBI Analyst Says Wait For Trend Reversal Before Entry

Equity

 The analyst highlights ₹900–₹910 as a critical support band to watch.


Nifty Reclaims 24,800, Smallcaps Shine As Markets Snap 3-Day Losing Streak; Tata Chemicals Surges On Upgrade

Broader market momentum lifted investor mood, while the retail sentiment turned ‘neutral’ on Stocktwits.


Trading Radar For July 28: TCS, Kotak Mahindra, Bank Of Baroda, Reliance Power And Adani Energy Are On Stock Watchlist

IndusInd Bank, Bharat Electronics, Adani Green Energy, and Torrent Pharma, among other companies, are scheduled to report their quarterly earnings later in the day

Tata Chemicals Overvalued? SEBI RA Warns Of Downside Risk Ahead Of Q1 Results

The analyst advises caution for short-term traders and sees ₹990 as a critical resistance level.


From Network18, Tata Chemicals To Repco Home Finance: SEBI RA Recommends Ten Breakout Stocks For Multi-Month Gains

 Stocks like Platinum Industries and Shivalik Rasayan are offering a strong upside, according to the analyst.


Tata Chemicals Ltd. is a holding company, which engages in the manufacture and sale of inorganic chemicals. It operates through the Basic Chemistry Products and Specialty Products. The Basic Chemistry Products segment offers soda ash and other bulk chemicals. The Specialty Products segment consists of nutrition solutions and advance materials. The company was founded by Jamsetji Nusserwanji Tata on January 23, 1939 and is headquartered in Mumbai, India.

Tata Chemicals Ltd.

Bearish Sentiment

Tata Chemicals has been in a persistent downtrend for almost two months, currently trading near ₹900. Over the past month, the stock has declined 7%. And analysts believe that caution is warranted until a clear reversal emerges.&nbsp;SEBI-registered <a href="https://stocktwits.com/Investogainerresearch">analyst Deepak Pal</a> said Tata Chemicals traded below all the key moving averages (20, 50, 100, 200-day), reflecting continued weakness in both short-term and long-term momentum.Other technical indicators, such as the Parabolic SAR, also showed a strong sign of selling pressure. The Relative Strength Index (RSI) stood around 34, suggesting the stock is in the oversold zone and showing initial signs of a possible reversal, yet no solid confirmation is visible.&nbsp;Pal flagged that the ₹900-910 support band is a highly significant psychological and historical zone, but despite previous buying interest at this level, no robust reversal signal has formed yet. Without confirmation, downside risk persists.<stembedurl>https://stocktwits.com/Investogainerresearch/message/631980118</stembedurl>Fundamental ViewThe stock is expensive with a P/E above 40 and P/B around 1.24-1.26. He added that weak earnings shows over the last few quarters, muted management commentary, and the announcement of TataChem’s exit from the F&amp;O segment have further weakened sentiment. And the formation of lower highs and lower lows has reinforced the bearish structure.&nbsp;But positives such as manageable debt, a 94% dividend payout, and long-term growth driven by specialty chemicals, global expansion, sustainability focus, and investments in advanced materials and green chemistry augur well for <a href="https://stocktwits.com/symbol/TATACHEM.NSE">Tata Chemicals</a>, according to Pal.&nbsp;&nbsp;At&nbsp;₹900, is this a buy?&nbsp;In the short term, Pal believes that the setup is still weak, and no clear reversal candle is present. He advised traders to avoid buying until reversal signals or volume spikes are observed. Any pullback may encounter resistance at ₹950–₹975, while a close below ₹900 could indicate further downside toward ₹865–₹850.&nbsp;For long-term investors, he recommended gradual, phased accumulation below ₹900. However, Pal cautioned that investors must wait for proper bottoming signals before large allocation. Staggered small-lot buying is a safer approach.&nbsp;&nbsp;Triggers to watchTata Chemicals will exit the F&amp;O segment in October 2025, adding to near-term price pressure. Investors will also be monitoring Q2 results (expected end-October or November).&nbsp;What Is The Retail Mood?Data on Stocktwits showed that retail sentiment moved from ‘neutral’ last month to ‘bearish’ last week.<figure class="image"><img style="aspect-ratio:808/90;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_13_151704_png_f69634d835.webp" alt="Screenshot 2025-10-13 151704.png" width="808" height="90"><figcaption>Tata Chemicals sentiment and message volume on Oct 13 as of 3:10 pm IST. | source: Stocktwits</figcaption></figure>Tata Chemicals shares have declined 14% year-to-date (YTD).For updates and corrections, email newsroom[at]stocktwits[dot]com.

Photographer: Dhiraj Singh/Bloomberg via Getty Images

 The analyst highlights ₹900–₹910 as a critical support band to watch.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	0.17	--	--	N/A
Q2 '26	0.99	--	--	N/A
Q1 '26	-0.05	--	--	N/A
Q4 '25	-0.29	--	--	N/A
Q3 '25	0.25	--	--	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

TATACHEM.NSE Earnings

Upcoming Earnings: Q3 '26

Historical Earnings